Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate long-lasting immune cells that may help slow the recurrence of pancreatic ductal ...

T cells are positioned at the frontline of the ... straightforward superhighway to become effective killers. But in cancer, CD8 cells take an offramp and end up on country roads, making them ...

NEW YORK - A Ludwig Cancer Research study has identified a key barrier to the efficacy of a promising combination of ...

A groundbreaking study published in Research (2025, DOI: 10.34133/research.0545) has elucidated the molecular mechanisms by which protein phosphatase 2A (PP2A) regulates CD8+ T cell-mediated immune ...

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to ...

Lung Cancer Test Predicts Survival in Early Stages ... between high levels of methylmalonic acid and the weakening of CD8+ T cells, shedding light on potential pathways through which aging may ...

In treating hematologic malignancies, engineered T-cell therapy outperforms standard transplantation with respect to chronic ...

Ten years of substantial work by Nathalie Labrecque's team at the Montreal Clinical Research Institute (IRCM) and the ...